ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with ketobemidone in 4 studies
| Studies (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Trials (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Recent Studies (post-2010) (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Studies (ketobemidone) | Trials (ketobemidone) | Recent Studies (post-2010) (ketobemidone) |
|---|---|---|---|---|---|
| 24 | 5 | 0 | 102 | 27 | 6 |
| Protein | Taxonomy | ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination (IC50) | ketobemidone (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 7 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 7 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 7 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, M; Elgen, K; Hagman, A; Larsson, L; Leward, S; Wolff, T | 1 |
| Kjaer, M; Nielsen, H | 1 |
| Anderson, P; Arnér, S; Bondesson, U; Boréus, LO; Hartvig, P | 1 |
| Christensen, AV; Larsen, JJ | 1 |
1 trial(s) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and ketobemidone
| Article | Year |
|---|---|
Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine.
Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Meperidine; Middle Aged; Morphine; Myocardial Infarction; Parasympatholytics | 1988 |
3 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and ketobemidone
| Article | Year |
|---|---|
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets | 1988 |
Clinical pharmacokinetics and oral bioavailability of ketobemidone.
Topics: Administration, Oral; Adult; Allylamine; Analgesics, Opioid; Biological Availability; Drug Combinations; Female; Gas Chromatography-Mass Spectrometry; Humans; Injections, Intravenous; Kinetics; Male; Meperidine; Middle Aged | 1980 |
The antinociceptive effect of ketobemidone in comparison with Ketogin.
Topics: Allylamine; Amines; Analgesics; Animals; Benzoquinones; Drug Combinations; Electroshock; Male; Meperidine; Mice; Pain; Quinones; Rats; Rats, Inbred Strains; Reaction Time; Sensory Thresholds; Species Specificity; Time Factors | 1983 |